Study Finds Mindfulness, Psychedelic Encounters Beneficial for Mental Well-Being

New research has discovered a positive link between the use of psychedelics, mindfulness practice and overall psychological well-being. Western University’s Tianhong Tim Qiu, the author of the study, stated that psychedelics were growing in popularity both in academic study and popular culture, noting that while most studies focused on the medical/clinical applications of these drugs as alternative therapy options for mental health conditions, users had claimed that the drugs were also beneficial to psychological well-being.

The researchers’ primary objective was to find out whether ordinary individuals who used psychedelics without treatment protocols, doctor supervision and a clinical setting, could benefit from the use of these drugs. Additionally, the researchers were curious to compare the parallels between psychedelics and mindfulness in an effort to understand both topics better.

For their research, the scientists recruited more than 1,200 individuals to take part in a survey that asked questions about their use of psychedelic drugs and their meditation practices. Participants were also required to complete the following questionnaires: the Mystical Experience Questionnaire and the Five Facet Mindfulness Questionnaire. Responses were used to measure aspects of the psychedelic experience and an individual’s general tendency to be mindful, respectively. In addition, participants were required to complete self-reported evaluations of negative and positive mood states over the last week, including stress, anxiety, depression, wisdom, meaning in life and life satisfaction.

The researchers found that individuals who admitted to using psychedelics had greater trait mindfulness and intense mystical experiences in comparison to others, while those who practiced meditation had higher scores on the measure of mystical experiences and trait mindfulness. Greater mindfulness was also linked to greater life satisfaction, greater wisdom, better mental health and better mood. Similarly, those who reported that they had more intense mystical experiences had greater life satisfaction, presence of meaning in life and positive affect.

In an interview, Qiu explained that the research demonstrated that mindfulness and psychedelic drugs held promise in the enhancement of the lives of healthy individuals as well as patients living with certain indications.

In their report, the researchers noted that the study had some limitations, including the fact that most of the individuals who took part in the study had been recruited from online communities related to meditation and psychedelics, which meant that it’s possible that the study didn’t recruit people who had had negative experiences with meditation or psychedelics.

The study’s findings were reported in the “Journal of Psychoactive Drugs.”

This study documenting the potential benefits of psychedelics on well-being suggest that the medicines being developed by companies such as Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) could find ever-increasing numbers of applications as users report their experiences and R&D teams put those claims to the test.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 888-902-4192 (U.S. Mobile Phones Only)

For more information please visit https://www.psychedelicnewswire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.psychedelicnewswire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.psychedelicnewswire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.